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Objectives. To test the hypothesis that individuals with regional and widespread pain disorders have an increased risk of mortality.
Methods. We conducted a prospective cohort study of 4515 adults. Subjects were an age- and sex-stratified sample who had participated in
a population study of pain occurrence during 1996. Based on those reports subjects were classified as having no pain, regional pain or
widespread pain. All subjects were identified on the National Health Service Central Register and followed up until April 2005, a total of
8.2yrs, at which time information was obtained on vital status, and if applicable, date and cause of death. The relationship between pain
status and subsequent death is expressed as mortality rate ratios with 95% CIs, adjusted for age, gender, ethnicity and practice.
Results. A total of 35.2% reported regional pain and 16.9% satisfied criteria for widespread pain. In comparison with those without pain, there
was a 20% and 30% increased risk of dying over the follow-up period among subjects with regional and widespread pain, respectively. The
specific causes of death in excess were cancer and cardiovascular disease. In addition, the mortality risk from both cancer and cardiovascular
deaths was found to increase as the number of pain sites that subjects reported increased.
Conclusions. This study supports a previous observation that persons with regional and widespread pain are at an increased risk of cancer
death. Possible mechanisms should be explored.
KEY WORDS: Pain, Musculoskeletal, Mortality, Cancer, Cardiovascular, Epidemiology, Population-based study, Prospective, Mechanisms.
Introduction
Pain that is widespread throughout the body is the cardinal
symptom of fibromyalgia [1]. Although the aetiology of this
syndrome is unclear a number of factors including trauma [2],
genetic factors [3–5] and psychological factors [6] have been
implicated in symptom onset. In the short term following onset,
the majority of cases of chronic widespread pain [7] and
fibromyalgia [8] tend to persist and are associated with a loss of
function and high levels of disability [9]. The long-term health
consequences of having chronic widespread pain is however
unclear.
We have previously demonstrated that subjects who reported
widespread pain in a population-based survey [10] had an
increased risk of mortality compared with those reporting no
pain over the following 9 yrs. Although deaths from external
causes (suicides and accidents) were increased in those with
widespread pain, these deaths were rare and the excess mortality
was almost entirely explained by deaths from cancer. Similar
relationships, albeit slightly attenuated, were observed for those
subjects reporting regional pain symptoms. A further analysis of
the same data set revealed that widespread pain was associated
with both cancer onset (incidence) and subsequent reduced
survival [11]. The strongest relationship was with breast and
prostate cancer, with smaller effects for gastrointestinal and lung
cancer. These relationships persisted after adjustment for age,
gender, social class and smoking. Although intriguing, this was
the first report of such a relationship and subsequent analyses
of data relating to chronic pain in general [12] or ‘widespread’ pain
[13, 14] have been equivocal. These discrepancies may be
explained by differences in the cohorts studied or uncontrolled
confounding effects. The observation requires replication in a
separate population-based cohort before investigating mechan-
isms that potentially link regional and widespread pain and
mortality. A cohort study conducted in 1996 in the North West
of England afforded a unique opportunity to do so.
The aim of the current study was to determine whether our
initial observation of a higher rate of cancer mortality among
subjects with regional and widespread pain would be confirmed
in a new general population sample.
Methods
Study design
The study was a population-based cross-sectional study of pain
and has been described in detail elsewhere [15, 16]. In brief,
subjects aged 16 yrs and over were recruited from three general
practices in North West England. The Tameside and Glossop
Research Ethics Committee approved the original study. The
follow-up study was approved by the North West Multi-centre
Research Ethics Committee and the University of Manchester
Committee on the Ethics of Research. The Office for National
Statistics approved the provision and use of death registration
data. An age- (16–44, 45–64, 65–74 and 75þ yrs) and sex-stratified
random sample of 750 subjects from each stratum was identified
from the combined practice lists. Of those, 86 subjects were
excluded from the original sample selected as they had recently
died or were terminally ill and were replaced with the next eligible
patient on the list. Each of the remaining subjects was mailed a
postal questionnaire between January and November 1996 with
non-responders being sent a reminder postcard 2 weeks after
the mailing of the initial questionnaire and a further copy of the
questionnaire 2 weeks later. A total of 4515 subjects returned the
questionnaire, giving a response rate of 78.5% after removing
from the denominator those subjects who had moved and were
unlikely to have received the study questionnaire (N¼228).
Younger subjects and men were more likely not to participate.
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The study questionnaire gathered demographic information: age,
gender and ethnicity. In the questionnaire, subjects were asked
whether they had experienced any pain in the past month that
had lasted for 1 week or longer. Those who answered ‘yes’ were
asked to indicate the site of their pain on a blank body manikin.
Subjects’ reports were scored using a 10-section coding schedule
with each section being scored 0 ‘pain not present’ or 1 ‘pain
present’.
Deprivation
Postcodes were available for each person who returned a health
survey. Each subject was assigned a Townsend score (a measure of
material deprivation) based on their postcode [17]. The Townsend
score includes four variables, derived from the Census: unemploy-
ment (percentage of economically active residents [aged 16þ yrs]
who are unemployed), overcrowding (percentage of private
households with more than one person per room), non-home
ownership (percentage of private households that are not owner
occupied) and lack of car ownership (percentage of private
households that do not own a car). The score is calculated by
summing the standardized scores for each variable (the unemploy-
ment and overcrowding percentages must first be transformed
using the natural log function). Scores >0 indicate higher levels of
deprivation, and negative values indicate less deprived areas.
Classification of pain status
On the basis of their pain reports, subjects were classified into one
of three groups: those reporting ‘no pain’; those reporting pain
which did not satisfy criteria for widespread pain were classified as
having ‘regional pain’; and those reporting pain that satisfied the
ACR criteria for widespread pain used in their classification of
fibromyalgia [1]. To satisfy these criteria subjects must have
reported pain on the left and right hand sides of the body, above
and below the waist, and pain in the axial skeleton. In addition,
we were interested to examine the relationship between increasing
number of pain sites reported by subjects and the risk of mortality.
To do so we summed the total number of sites in which subjects
had reported pain constructing a ‘pain total score’ variable with
scores ranging from 0 to 10.
Subject follow-up and ascertainment of vital status
All subjects were followed up until either death or 30 April 2005,
a total of 8 yrs of follow-up for those still alive. Demographic
details of all subjects were sent to the National Health Services
Central Register, which holds information on all subjects who
have registered with a general practitioner. In the United
Kingdom, 95% of subjects are registered with a general practi-
tioner. All subjects in the current study were successfully identified
and were ‘flagged’ enabling them to be tracked over time. The
NHS register is linked to official records that allow vital status
and, if dead, cause of death to be determined. Underlying cause of
death was coded using the International Classification of Diseases
(ICD) 10th revision [18].
Statistical analysis
The number of person-years at risk of dying was calculated from
the date of subjects returning their baseline questionnaire to either
the end of the follow-up period (30 April 2005) or if the person
had died, the date of death. The mortality rates in the ‘no pain’,
‘regional pain’ and ‘widespread pain’ groups were then calculated.
We then calculated standardized mortality ratios (SMRs), i.e. the
ratio of observed to expected number of deaths, standardized to
the population of North West England. SMRs were calculated
for the whole study population and separately by pain status
at baseline. The number of expected deaths was obtained by
multiplying the numbers of person-years at risk by the age, gender
and calendar year-specific mortality rates for the North West
England population obtained from the Office for National
Statistics. For each SMR, a 95% CI was calculated assuming
that the number of deaths followed a Poisson distribution. The
relationship between pain status and subsequent all-cause
mortality was quantified using a Cox proportional hazards
model. Similar analyses were conducted to examine the relation-
ship with cause-specific mortality. For all analyses the ‘no pain’
group was classified as the referent group. To explore the
relationship between the number of pain sites reported and
mortality the total pain score variable described above was
entered as a continuous variable. To take account of the unequal
probability stratified sampling design, age–sex stratum-specific
sampling probability weights were applied to each subject and
‘weighted’ Cox proportional hazards models were fitted [19].
All models were adjusted for the potential confounding effects of
age, gender, practice, Townsend score (in quartiles) and ethnicity
(as defined in Table 1). Our results are presented as mortality rate
ratios (MRRs) with 95% CI. None of the estimated models
violated the assumption of proportionality over time.
Role of the funding source
The study sponsors did not influence the study design, collection,
analysis and interpretation of data, nor the writing of the report
and decision to submit the article for publication.
Results
Of the 4515 subjects who completed the baseline survey, 2331
(51.6%) were females. Pain status was not available for 171
(3.8%). Of the remaining subjects, 1993 (44.1%) reported no pain,
1590 (35.2%) had regional pain and 761 (16.9%) were classified as
having widespread pain (Table 1). Compared with those reporting
no pain, subjects with widespread pain were more likely to be
females (47.7% and 59.9%, respectively, P¼0.00) and older
(mean age: 56.0 and 64.7, respectively; P¼0.00). The majority
of subjects were white (n¼4270, 95.9%) and there were no
statistically significant differences in ethnicity between pain
groups.
Overall, 4344 subjects contributed 30440 person-years of
follow-up to the study. Follow-up ranged from 0.4 to 8.3yrs. As
shown in Table 2, those subjects who initially reported no pain
TABLE 1. Characteristics of study population
No pain
(n¼1993)
Regional pain
(n¼1590) P*
Widespread pain
(n¼761) P**
Age, mean (SD), yrs 56.0 (19.9) 62.5 (17.3) 0.00 64.7 (15.4) 0.00
Gender, female, n (%) 951 (47.7) 825 (51.9) 0.01 456 (59.9) 0.00
Practice, n (%)
1 715 (46.9) 545 (35.8) 0.08 264 (17.3) 0.01
2 602 (42.6) 536 (37.9) 275 (19.5)
3 676 (48.1) 509 (36.2) 222 (15.8)
Ethnic group, n (%)
a
White 1889 (95.7) 1514 (96.4) 0.75 719 (95.5) 0.76
Afro-Caribbean 38 (1.9) 30 (1.9) 15 (2.0)
Indian 21 (1.1) 12 (0.8) 10 (1.3)
Pakistani 6 (0.3) 2 (0.1) 2 (0.3)
Bangladesh 9 (0.5) 5 (0.3) 6 (0.8)
Chinese 4 (0.2) 2 (0.1) 0 (0.0)
Other 7 (0.4) 5 (0.3) 1 (0.1)
aExcludes subjects with missing data. *Regional pain compared with no pain, P-value by
chi-squared test. **Widespread pain compared with no pain, P-value by chi-squared test.
Chronic pain and mortality 75had the lowest mortality rate (27.2/1000 person-years), followed
by those with regional pain (37.5/1000 person-years) while those
with widespread pain had the highest mortality rate (41.9/1000
person-years).
The overall rate of mortality in our study population was
similar to that of the North West of England (SMR¼1.05; 95%
CI 0.99, 1.12). When we examined the standardized rate stratified
by pain status we found a similar mortality experience among
those subjects reporting no pain (SMR¼1.03; 95% CI 0.96, 1.10).
However, reporting regional pain (SMR¼1.10; 95% CI 0.95,
1.27) or widespread pain (SMR¼1.14; 95% CI 0.99, 1.30) was
associated with an elevated all-cause mortality risk.
After adjusting for the effects of age, gender, Townsend score
and ethnicity, the weighted analysis showed that subjects with
regional pain were 20% and those with widespread pain 30%
more likely to die over the 8-yr follow-up period when compared
with those with no pain. When we examined the relationship
between pain status at baseline and subsequent cause-specific
mortality (Table 3) regional pain was associated with an elevated
mortality risk from cancer (MRR¼1.3; 95% CI 0.98, 1.8) but not
cardiovascular disease (MRR¼1.1; 95% CI 0.93, 1.6). Subjects
with widespread pain had an elevated risk of deaths from cancer
(MRR¼1.8; 95% CI 1.3, 2.6) and cardiovascular disease
(MRR¼1.3; 95% CI 0.99, 1.6), although the latter relationship
was not statistically significant. We hypothesized that these
relationships were explained by pain arising from comorbid
disease at the time of questionnaire completion. However, when
we excluded those subjects who had died during the first year of
follow-up the relationship with widespread pain remained
unchanged for both cancer and cardiovascular deaths. The small
number of deaths attributable to specific cancer sites prohibited
a more detailed analysis. Pain status was not associated with
deaths from any other cause. We then examined the relationship
between the total pain score and cause-specific mortality.
An increasing number of pain sites was associated with both
cancer (MRR¼1.06; 95% CI 1.01, 1.1) and cardiovascular
(MRR¼1.02; 95% CI 0.99, 1.1) deaths.
Discussion
We have previously reported an increased mortality rate in
subjects who reported regional and widespread pain in a
community-based study of pain [11]. In that report, the excess
mortality was almost entirely due to deaths from cancer. We have
replicated those findings in a large population in the current study,
lending support to our original observation. We have also
observed an increased risk of cardiovascular mortality that we
had not observed in our previous study, although that relationship
did not reach statistical significance after adjustment was made for
putative confounding factors. On examination of the relationship
between these specific causes of death we found that the risk
of death increased as the number of reported pain sites increased.
Although these results replicate our previous findings of cancer-
related mortality in a separate cohort of subjects, we have not
necessarily identified incident cases of cancer. One could argue that
the musculoskeletal pain reported at baseline may be symptomatic
of underlying disease, i.e. cancer, and that it is unsurprising to
observe the relationship. If that were true we would expect that the
relationship would primarily be evident during the immediate
period of follow-up. However, this was not the case as the
relationship was proportional across all years of follow-up and
persisted after excluding those subjects who had died during the
first year of follow-up. In addition, we have previously demon-
strated that widespread pain is associated with both cancer
incidence and, following cancer onset, reduced survival [11].
There have been relatively few studies that have examined the
mortality experience of persons with regional or widespread pain
disorders. A clinic-based study [14] explored the cancer incidence
experience of 1353 patients (1269 women, 84 men) referred to
secondary care with ‘possible’ fibromyalgia. Of those, 1189 (88%)
cases satisfied the ACR criteria [1], 131 (10%) did not fulfil
criteria, while medical records were unavailable for 33 (2%)
subjects. There was an increased risk of cancer among women
(standardized incidence ratio¼1.4; 95% CI 1.1, 1.9) although
these analyses were based on a small number of cancers (n¼50).
In a cohort study, fibromyalgia patients who satisfied the ACR
criteria were found to have an increased risk of all-cause mortality
(SMR¼1.5; 95% CI 1.2, 1.9) and specifically accidental deaths
(SMR¼4.5; 95% CI 2.0, 10.1), infections (SMR¼4.5; 95% CI
1.7, 11.9) and pneumonia (SMR¼3.3; 95% CI 1.2, 8.8) over
25yrs of follow-up [20]. A population-based study reported a
higher 10-yr mortality rate among persons with fibromyalgia
(22.6/1000 person-years) when compared to those without
fibromyalgia (16.6/1000 person-years) [21]. The difference in
mortality rates was not significant when adjusted for age and
gender using a proportional hazards model. However, this
analysis was based on only 54 subjects with fibromyalgia and
12deaths over the study period. In a population-based study of
women, reporting ‘any’ [odds ratio (OR)¼1.1; 95% CI 0.9, 1.4] or
‘chronic’ (OR¼1.01; 95% CI 0.8, 1.3) pain [12], symptoms were
TABLE 2. Pain status and subsequent all-cause mortality risk
Crude Adjusted
Pain status Number in group Person-years of follow-up Number of deaths Rate
a MRR (95% CI)
b MRR
b (95% CI)
b MRR
c (95% CI)
b
No pain 1993 14308 389 27.2 Referent – Referent – Referent –
Regional pain 1590 10954 411 37.5 1.9 1.6, 2.3 1.2 1.02, 1.4 1.2 1.01, 1.4
Widespread pain 761 5178 217 41.9 2.4 1.9, 2.9 1.3 1.1, 1.5 1.3 1.1, 1.5
aPer 1000 person-years.
bAdjusted for age, sex, practice and ethnic group.
cPlus adjustment for Townsend score.
TABLE 3. Pain status and subsequent mortality risk: specific cause of death
Crude Adjusted
Regional pain Widespread pain Regional pain Widespread pain
Cause of death ICD-10 rubric Number of deaths MRR 95% CI MRR 95% CI MRR
a 95% CI MRR
a 95% CI
All cancers C00-D48 228 2.1 1.5, 3.1 3.0 1.9, 4.5 1.3 0.98, 1.8 1.8 1.3, 2.6
Cardiovascular disease I00-I99 478 2.1 1.6, 2.6 2.7 2.0, 3.6 1.1 0.93, 1.6 1.3 0.99, 1.6
Respiratory disease J00-J99 174 1.4 0.9, 2.0 1.8 1.1, 2.7 0.8 0.6, 1.1 1.0 0.7, 1.6
All external causes V01-Y09 12 1.4 0.4, 4.9 1.3 0.2, 7.3 0.8 0.2, 3.1 0.6 0.1, 3.8
Other –
b 126 1.8 1.1, 2.8 1.6 0.9, 2.9 1.0 0.7, 1.4 0.8 0.5, 1.4
aAdjusted for age, sex, Townsend score, practice and ethnic group. Subjects with no pain are the referent group for all analyses.
bAll other codes excluding those listed above.
76 J. McBeth et al.not associated with increased all-cause mortality. Women with
chronic chest pain had an increased all-cause mortality
(OR¼1.75; 95% CI 1.2, 2.6). The authors were unable to identify
and explore the relationship among subjects with widespread pain
although reporting pain at regional sites was associated with an
increased risk of developing cancer: head (OR¼1.5; 95%CI 1.03,
2.2) and abdominal (OR¼1.6; 95%CI 1.01, 2.4) pain.
More recently, we explored the mortality experience among
subjects reporting ‘widespread pain’ (reporting pain in four or
more joints) in a population-based cohort study conducted in
Finland [13]. Overall, the risk of death was not increased among
those with ‘widespread pain’ (relative risk¼0.9; 95% CI 0.7,
1.00). This discrepancy with our original and current observation
could be explained by the different populations studied, the
different aetiological processes by which these two populations
may come to have widespread pain and the associated comorbid-
ities. It is less important that the studies were conducted in rural vs
urban areas, but more important that the factors associated with
the presence of symptoms are likely to differ. Thus, in the Finnish
study we could hypothesize that reports of widespread pain are
more likely to be associated with mechanical factors and in
the UK study with psychological factors. That alone would not
be important; however, it may also be the case that the two
populations also have different factors associated with the
presence of widespread pain—for example, low physical activity
that may explain the increase in mortality.
It is important to note that there may be unmeasured factors
including smoking and morbidity at the time of survey comple-
tion, that may be independently associated with regional and
widespread pain and cancer mortality, and that may act to
confound the relationship we have observed. However, we have
previously adjusted the relationship for the possible confounding
effects of socioeconomic status, smoking and levels of psycholo-
gical distress [10], and in the current study for ethnic group and
found that the relationship persisted.
The replication of a relationship between musculoskeletal
pain and mortality should encourage the investigation of the
mechanism of association, and in particular the determination of
whether premature mortality can be avoided. The relationship is
with both regional and widespread pain. We have also reported
a novel observation of an increasing risk of mortality with an
increasing number of pain sites reported suggesting a dose–
response relationship. We have previously proposed a number of
mechanisms that may explain this observation [11] including the
influence of insulin-like growth factor-1 and low levels of physical
exercise. In our previous report, widespread pain was most
strongly associated with female breast and prostate cancer and
both cancers are associated with low levels of physical exercise.
We have reported in this study a moderate relationship with
cardiovascular mortality, an outcome that is also associated with
reduced physical activity levels. The interesting question arises
whether the onset of regional and widespread pain leads to long-
term reduced levels of physical exercise that ultimately lead to an
increased risk of cancer and cardiovascular mortality. One could
hypothesize a negative correlation between an increasing number
of pain sites reported and levels of physical activity that may lead
to an increased mortality risk. Studies are under way to help
elucidate possible mechanisms underlying these relationships.
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Rheumatology key messages
  Chronic widespread pain is associated with an increased risk of
mortality.
  Pain is associated with cancer and cardiovascular deaths.
  The mechanism of association is unclear.
Chronic pain and mortality 77